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Pain resulting from chronic pancreatitis is often debilitating and diﬃcult to manage. Many approaches have been used to treat
thesepatients,includingnarcoticanalgesia,antidepressants,pancreaticenzymes,octreotide,denervationprocedures,suchasceliac
plexus block, and various palliative, decompression, or drainage procedures. Many of these procedures can be performed endo-
scopically, while others require a more invasive, surgical approach. The eﬀectiveness of these therapies is not only highly variable
but also often controversial. This review will discuss the endoscopic options for pain management in patients with chronic pan-
creatitis and their utility in treating this diﬃcult disease.
1.Introduction
Pain resulting from chronic pancreatitis is often diﬃcult to
manage. Many approaches have been used to treat these pa-
tients, including narcotic analgesia, antidepressants, pan-
creatic enzymes, octreotide, denervation procedures (most
commonly CPB), and various palliative, decompression,
or drainage procedures [1–13]. The eﬀectiveness of these
therapies is not only highly variable but also often contro-
versial. Opioid analgesics are probably used most often and
can treat pain eﬀectively, but they are associated with num-
erous side eﬀects, including constipation, delirium, nausea,
and the potential for addiction in patients with chronic pan-
creatitis [14, 15]. Nonpharmacologic methods of pain con-
trol may improve quality of life and minimize drug-relat-
edsideeﬀects[14].Endoscopicmanagementofpaininchro-
nic pancreatitis consists of procedures aimed at reducing
neurogenicsensation,suchasceliacplexusblock,ordrainage
procedures aimed at alleviating outﬂow obstruction of the
pancreatic duct.
2. CeliacPlexusBlock
The celiac plexus lies anterior to the aorta at the level of the
celiac artery. Most of the sensory nerves returning from the
pancreas and other intraabdominal viscera pass through the
celiac ganglion and splanchnic nerves. Interruption of these
ﬁbers may lessen pain in patients with chronic pancreat-
itis[16].Celiacplexusblock(CPB),atemporizingtreatment,
most commonly refers to injection of a steroid and long-
acting local anesthetic into the celiac plexus to control
pain associated with chronic pancreatitis. In contrast, celiac
plexus neurolysis (CPN) generally refers to injection of alco-
hol or phenol, a more permanent agent, into the celiac axis
area [16]. This technique induces a chemical splanchnicec-
tomy that ablates the nerve ﬁbers that transmit pain and is
used in patients with pancreatic cancer; however, it is not
usually employed in patients with pain mediated by chronic
pancreatitis.
CPB has traditionally been performed via various per-
cutaneous and surgical approaches [17]. Recently, the EUS-
guided approach has gained acceptance since it oﬀers the
most direct access to the celiac plexus. Wiersema and co-
workers [14, 16, 18] recognized the anatomic advantage
that EUS provides in visualizing the celiac region and
weresuccessfulin performingtransgastricEUS-guided celiac
plexus blocks with results similar to the more traditional ap-
proaches. The timing of the block relative to pain onset
may predict response. One study which aimed to look at
CPN showed that it was more eﬀective when the block was
performed early after pain onset [19]. This result was post-
ulated to be related to contribution of visceral and somatic
nerveslateinthediseaseandpainapparentlyderivingmainly2 Gastroenterology Research and Practice
from the celiac plexus early on; however, it is unclear if this
translates into patients with chronic pancreatitis and the use
of CBP for pain relief [16, 19]. More recently, it has been
proposed that direct injection into the celiac ganglia, multi-
ple injections in the area of the ganglia, or bilateral injections
around the celiac ganglia are safe and may be more beneﬁcial
in providing sustained pain relief [20–22]. These studies
are contradictory, however, and better prospective trials are
needed to determine if these approaches make an improve-
ment over the standard technique of EUS-guided CPB.
Several studies have shown that EUS-guided CPB has a
beneﬁcial role in the treatment of pain induced by chronic
pancreatitis [23, 24]. An initial study of 18 patients with
chronic pancreatitis showed a reduction in pain in 50% (5
of 10) of EUS-guided CPB compared with 25% (2 of 8)
of CT-guided blocks [23]. This improvement in pain per-
sisted for up to 24 weeks in 30% of responders. A cost
comparisonshoweda$200savingforEUS-guidedCPBcom-
pared with CT-guided CPB. Another report of 90 patients
by the same investigators found a signiﬁcant improvement
in overall pain scores in 55% at 4 weeks and 8 weeks of
follow-up [24]. However, a persistent beneﬁt beyond 24
weeks was observed in only 10% of patients. Pain relief was
more likely in older patients (>45 years old) and patients
who had not had previous surgery for chronic pancreatitis. A
recent meta-analysis aimed to look at the eﬃcacy of CPB for
improving pain in patients with chronic pancreatitis showed
that the overall percentage who obtained pain relief with
this procedure was 32.7% (Table 1) and that very few good
quality studies exist [25]. A major issue with all of these
studies is the lack of long-term follow-up. Further, prospec-
tive studies with long-term follow-up are needed to clarify
what role EUS-guided CBP will play in the management of
painful chronic pancreatitis.
CPB is a generally eﬀective, safe, and well-tolerated pro-
cedure. The three most common complications are transient
hypotension (20% to 40%), transient diarrhea (4% to 38%),
and transient increase in pain (9%), which are expected in
C P Bp e r f o r m e dv i aa n yr o u t e[ 16, 26, 27]. Interruption of
the plexus can result in a sympathetic blockade [28]. Clinical
manifestations of sympathetic blockade can include diarrhea
andhypotensionresultingfromarelativeunopposedvisceral
parasympathetic activity. Mesenteric vasodilation accounts
for the hypotension, which resolves in approximately 2 days.
Diarrhea and increase in baseline pain are also usually lim-
ited to 2 days. Less common complications include unilateral
paresis or paraplegia, pneumothorax, loss of sphincter func-
tion, retroperitoneal bleeding, renal puncture, and pro-
longed gastroparesis [14, 16, 27, 29]. In addition, cephalic
spread of the neurolytic agent may result in involvement of
the cardiac nerves and plexus aﬀecting the heart and sur-
rounding thoracic structures [30]. Compared to alternative
approaches, EUS guidance may decrease the incidence of
complications because the needle does not traverse the
paraspinal region or somatic nerves or traverse the dia-
phragm and pleural space [1, 14, 16]. Infectious compli-
cations are uncommon but potentially serious. In a series
of 90 patients, only 1 patient developed an infectious com-
plication (peripancreatic abscess), which resolved with
Table 1: Meta-analysis of EUS-guided celiac plexus block for
chronic pancreatitis. The lower end of the conﬁdence interval was
used as the overall percentage of pain relief (adapted from Kaufman
et al. [25]).
Study Pain relief reported out of
total patient (average) 95% CI
Gress et al. [23] 5/10 (50%) (0.2836-1)
Gress et al. [24] 50/90 (56%) (0.4689-1)
Levy et al. [20] 5/13 (38%) (0.2217-1)
O’Toole et al. [31] 20/31 (65%) (0.4912-1)
LeBlanc et al. [21] 27/51 (53%) (0.4215-1)
Stevens et al. [32] 16/26 (62%) (0.3272-1)
Over all Studies 123/221 (56%) (0.3272-1)
a 2-week course of antibiotics [24]. The authors reasoned
that there might have been a predisposition to infection ow-
ing to gastroduodenal colonization with bacteria because the
patient was taking a proton pump inhibitor. They suggested
thatprophylacticantibioticsshouldbeconsideredinpatients
who are receiving acid suppression.
3. ERCP-GuidedTherapies
Patients with chronic pancreatitis associated with dilation of
the main pancreatic duct, stone disease, or strictures may
develop symptoms of severe abdominal pain. In addition to
celiac plexus block, this pain can be treated endoscopically
with procedures aimed at draining the main pancreatic
duct, removing stones, and dilating strictures. ERCP with
pancreatic sphincterotomy, dilation of strictures, placement
of stents, and stone extraction has become a mainstay of
therapyinpatientswithpainfulchronicpancreatitisasrecent
studies have shown that on average, over 65% of patients
with strictures or stones treated with endoscopic therapy
have shown improvement in their pain [33]. Many studies
over the last 20 years have attempted to address the question
as to whether endoscopic therapy for the control of pain
in chronic pancreatitis is eﬀective. The results of selected
publishedstudiesonpainreliefafterendotherapyforchronic
pancreatitis are summarized in Table 2.
Experienced practitioners with advanced ERCP skills
should only perform endoscopic therapies for chronic pan-
creatitis. In experienced hands, endoscopic pancreatic sphin-
cterotomy is safe and eﬀective and allows the therapeutic
endoscopist access to the main pancreatic duct. This is
usually performed under direct visualization with a pull-
type sphincterotome after deep cannulation and guidewire
insertion. The major risks of the procedure include pancre-
atitis, bleeding, and perforation. In addition, there is a risk
of pancreatic sphincter stenosis that is considered a late com-
plication after pancreatic sphincterotomy [34]. Once access
to the main pancreatic duct is achieved, small stones can be
removed endoscopically with success [35]. However, large,
impacted stones usually require extracorporeal shock wave
lithotripsy (ESWL) prior to attempted endoscopic removal.
ESWL is a low-risk procedure where calciﬁc pancreatic duct
stones are usually identiﬁed by X-ray prior to the procedure.Gastroenterology Research and Practice 3
Table 2: Selected studies on pain relief with pancreatic endother-
apy.
Author Year Number of
cases
Procedure
performed
Pain relief
(%)
McCarthy et al.
[44] 1988 33 PS, stent 80
Sauerbruch et al.
[45] 1992 24 PS, stent,
ESWL 50
Delhaye et al. [46] 1992 123 PS, stent,
ESWL 37
Binmoeller et al.
[47] 1995 93 PS, stent,
ESWL 64
Adamek et al. [48] 1999 70 PS, stent,
ESWL 54
R¨ osch et al. [33] 2002 1018 PS, stent,
ESWL 85
D´ ıte et al. [49] 2003 36 PS, stent,
ESWL 65
Delhaye et al. [41] 2004 56 PS, stent,
ESWL 78
Gabbrielli et al.
[50] 2005 22 PS, stent,
ESWL 100
Costamagna et al.
[43] 2006 19 PS, stent
(multiple) 84
PS; pancreatic sphincterotomy, ESWL: extracorporeal shock-wave litho-
tripsy.
Then a ﬂuid cushion is applied to the front and back of the
patient, and shock waves are passed through the identiﬁed
stones. This results in fragmentation of stones in chronic cal-
ciﬁc pancreatitis allowing the endoscopist to then attempt to
obtain complete clearance of the main pancreatic duct [35].
Multiple sessions of ESWL may be required in attempt to
clear the pancreatic duct, and the success rate for complete
clearance of the main pancreatic duct and resolution of
pain has been at best approximately 75% [36]. There are
some studies to suggest that ESWL alone, without combined
endoscopic therapy, may be enough in the treatment of
chronic calciﬁc pancreatitis. A randomized controlled trial
by Dumonceau and colleagues in 2007 aimed to answer this
question [37]. There were 55 patients in the study, and the
follow-up was 2 years. They were able to show that ESWL
is a safe and eﬀective treatment alone, without combined
endoscopictherapy.MoststudieslookingattheroleofESWL
performedtodatehaveshownmixedeﬃcacyduetothesmall
samplesizesinthestudies. Arecentmeta-analysisperformed
by Guda et al. aimed to overcome this problem and included
17 studies from 1989 to 2002 with a total of 588 subjects.
Their data showed that ESWL is both eﬀective in clearance
of stones from the pancreatic duct and in relief of pain from
chronic pancreatitis [38]. In addition, there is newer liter-
ature to suggest that the timing of ERCP after ESWL may in-
crease the success rate of this procedure [39]. This study
suggests waiting at least 2 days after ESWL before attempting
ERCP and ductal clearance possibly due to ESWL-induced
edema of the pancreatic duct. Long-term success of these
procedures is variable, and many patients will have recurrent
pain attacks after short-term successful clearance of the main
pancreatic duct. This is thought, at least partially, to be due
to stone migration or recurrence and responds to repeated
attempts at endoscopic clearance of the main pancreatic duct
[40]. Other studies have suggested that endotherapy with
ESWL and pancreatic duct drainage will provide long-term
pain relief for up to two-thirds of patients [41]. The authors’
practiceistoperformESWLonpatientswithchronic,calciﬁc
pancreatitis, associated with large pancreatic duct stones that
are not amenable to endoscopic removal at the time of initial
ERCP. After ESWL is completed, ERCP and repeat attempt at
ductal decompression are then performed.
Pancreatic duct strictures are usually caused by ﬁbrosis
around the main pancreatic duct as a result of the chronic
inﬂammation seen in the disease process. Strictures that are
focal and located towards the head and neck region of the
pancreas are more amenable to endoscopic therapy. A recent
prospective study was able to show a decrease in pain after
ERCP with dilation and stent placement in 89% of patients;
however after 2 years of follow-up 30% of patients had
relapsedandrequiredfurthertherapy[42].Inattempttoper-
form more deﬁnitive therapy for pancreatic duct stric-
tures, some investigators have attempted placing multiple
stents into the main pancreatic duct in order to dilate refrac-
tory strictures and improve PD drainage. Costamagna and
colleagues were able to show that during a mean follow-
up of 38 months, 84% of patients remained asymptomatic.
Only5.5%ofpatientshadapersistentstrictureaftermultiple
stenting, and only 10.5% of patients had symptomatic stric-
ture recurrence [43].
4.SurgicalTreatmentOptions
It is the prevailing belief by most endoscopists, including the
authors, that endoscopic therapy should be attempted prior
to surgical intervention. Endoscopic therapy is less invasive
and shows similar results in the short term compared with
surgical alternatives. D´ ıte and colleagues presented data on
the ﬁrst randomized controlled trial comparing endoscopic
versus surgical therapy, the latter consisting of resection and
drainage procedures [49]. A total of 72 patients were rando-
mized, and the initial success rate was similar in both groups.
However, long-term follow-up favored complete absence of
pain in the surgical group. This study was limited by the fact
that ESWL was not performed, and repeat endoscopic ther-
apy was not allowed for pain recurrence. A more recent ran-
domized controlled trial comparing surgical drainage (pan-
creaticojejunostomy) versus endoscopic therapy showed that
the surgical alternative was superior in improving pain in
patients with chronic pancreatitis and a dilated pancreatic
duct[51].Althoughthisstudyhasbeencriticizedforitssmall
numbers, possible selection bias, and lack of rigorous endo-
scopictherapy,Cahenandcolleagueswereabletoshowcom-
plete or partial pain relief in 75% of surgically treated pa-
tients versus a 32% success rate in endoscopically treated
patients. In addition, these investigators have recently pub-
lished their 5-year follow-up results showing that 68% of the
endoscopically treated patients required additional drainage4 Gastroenterology Research and Practice
procedures, compared with 5% in the surgery group (P =
0.001) [52]. They also report that 47% of the patients in
the endoscopy group eventually received surgery. In the long
term, despite comparable levels of quality of life and pancre-
atic function between the surgical and endoscopic manage-
ment group, surgery was still superior, in terms of pain relief
(80% versus 38%, P = 0.042). Although endoscopic therapy
is still considered ﬁrst-line treatment, these randomized
trialscomparingsurgicalandendoscopictherapyshouldgive
the endoscopist pause to think about the procedures being
oﬀered to a patient for the treatment of pain in chronic
pancreatitis.
In conclusion, endoscopic therapy aimed at treating
pain in patients with chronic pancreatitis consists of EUS-
guided celiac plexus block and therapeutic ERCP procedures
combined with ESWL that are all aimed at draining an
obstructedpancreaticduct.Asaresulttheyhavethepotential
to work well in patients with large duct disease, but they do
not work well in patients with small duct chronic pancreati-
tis. Endoscopic management is safe and eﬀective for many
patients,butpainreliefisoftenshortlivedrequiringmultiple
repeat procedures. Endoscopic technologies as well as thera-
peutic techniques continue to evolve, and as such, improve-
ments will likely be seen in the endoscopic management of
chronic pancreatitis in the future.
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